ARC Clinical Research at William Cannon
Austin, Texas, United States
Medical clinic in Austin, Texas
111 W William Cannon Dr #312, Austin, TX 78745
About ARC Clinical Research at William Cannon
"ARC Clinical Research William Cannon is a medical research clinic designated for clinical research projects."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Exact Sciences Corporation
2
Pfizer
2
Cognoa, Inc.
1
Eli Lilly and Company
1
ModernaTX, Inc.
1
Clinical Trials at ARC Clinical Research at William Cannon
During the past decade, ARC Clinical Research at William Cannon conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"
2019-11-15
2023-03-31
Active, not recruiting
29,000
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
2019-11-15
2023-03-31
Active, not recruiting
24,000
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
2020-06-15
2025-01-31
Recruiting
1,633
EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
2021-07-16
2022-04-25
Completed
2,246
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
2021-08-25
2022-07-25
Terminated
1,411
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
2021-10-26
2026-04-06
Recruiting
7,300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ARC Clinical Research at William Cannon" #1 sponsor was "Exact Sciences Corporation" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Cognoa, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "ModernaTX, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at ARC Clinical Research at William Cannon
According to Clinical.Site data, the most researched conditions in "ARC Clinical Research at William Cannon" are
"COVID-19" (2 trials), "Colorectal Cancer" (2 trials), "Autism Spectrum Disorder" (1 trials), "Cytomegalovirus Infection" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "ARC Clinical Research at William Cannon" in a lesser frequency.
Clinical Trials Intervention Types at ARC Clinical Research at William Cannon
Most popular intervention types in "ARC Clinical Research at William Cannon" are "Drug" (3 trials), "Diagnostic Test" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials), "Blood Sample Collection" (1 trials) and "Cognoa ASD diagnostic device" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ARC Clinical Research at William Cannon
The vast majority of trials in "ARC Clinical Research at William Cannon" are
6 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at ARC Clinical Research at William Cannon
Currently, there are NaN active trials in "ARC Clinical Research at William Cannon".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in ARC Clinical Research at William Cannon,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ARC Clinical Research at William Cannon, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".